INDUSTRIAL COLLABORATION AGREEMENTIndustrial Collaboration Agreement • November 14th, 2002 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • New York
COLLABORATION AGREEMENT effective as of February 1, 2000 (the “Effective Date”), by and among INTERNATIONAL AIDS VACCINE INITIATIVE, a not-for-profit corporation with its principal offices at 810 Seventh Avenue, New York, New York 10019 (hereinafter referred to as “IAVI”), CHILDREN’S RESEARCH INSTITUTE, a not-for-profit corporation with its principal offices at 700 Children’s Drive, Columbus, Ohio 43205 (hereinafter referred to as “Children’s”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, WA 98101 (hereinafter referred to as “TGC”).
AMENDMENT NO. 3 TO INDUSTRIAL COLLABORATION AGREEMENTIndustrial Collaboration Agreement • January 13th, 2004 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • New York
THIS AMENDMENT TO INDUSTRIAL COLLABORATION AGREEMENT is made the 24th day of December, 2003 by and among INTERNATIONAL AIDS VACCINE INITIATIVE, INC., a Delaware not-for-profit corporation with its principal offices at 110 William Street, 27th Floor, New York, New York 10038 (hereinafter referred to as “IAVI”), CHILDREN’S RESEARCH INSTITUTE, a not-for-profit corporation with its principal offices at 700 Children’s Drive, Columbus, Ohio 43205 (hereinafter referred to as “Children’s”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (hereinafter referred to as “TGC”).
AMENDMENT NO. 1 TO INDUSTRIAL COLLABORATION AGREEMENTIndustrial Collaboration Agreement • March 27th, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances)
THIS AMENDMENT TO INDUSTRIAL COLLABORATION AGREEMENT is made the 14th day of March, 2003 by and among INTERNATIONAL AIDS VACCINE INITIATIVE, INC., a Delaware not-for-profit corporation with its principal offices at 110 William Street, 27th Floor, New York, New York 10038 (hereinafter referred to as “IAVI”), CHILDREN’S RESEARCH INSTITUTE, a not-for-profit corporation with its principal offices at 700 Children’s Drive, Columbus, Ohio 43205 (hereinafter referred to as “Children’s”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (hereinafter referred to as “TGC”).
AMENDMENT NO. 2 TO INDUSTRIAL COLLABORATION AGREEMENTIndustrial Collaboration Agreement • October 31st, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • New York
This amendment number two (“Amendment”) to the industrial collaboration agreement is made the 1st day of August, 2003 by and among INTERNATIONAL AIDS VACCINE INITIATIVE, INC., a Delaware not-for-profit corporation with its principal offices at 110 William Street, 27th Floor, New York, New York 10038 (hereinafter referred to as “IAVI”), CHILDREN’S RESEARCH INSTITUTE, a not-for-profit corporation with its principal offices at 700 Children’s Drive, Columbus, Ohio 43205 (hereinafter referred to as “Children’s”), and TARGETED GENETICS CORPORATION, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (hereinafter referred to as “TGC”).
